Top

Published in:

15-05-2023

Protective Role of Short-term Aerobic Exercise Against Zinc Oxide Nanoparticles-Induced Cardiac Oxidative Stress Via Possible Changes of Apelin, Angiotensin II/Angiotensin II Type I Signalling Pathway

Authors: Masoumeh Habibian, Sara Biniaz, Seyyed Jafar Moosavi

Published in: Cardiovascular Toxicology | Issue 5-6/2023

Abstract

This study examined the protective role of short-term aerobic exercise on ZnO NPs-induced cardiac oxidative stress and possible changes of apelin, angiotensin II (AngII) and angiotensin II type I receptor (AT1R) signalling pathway. Thirty-five male Wistar rats were randomized into five groups of seven rats, including control, saline, ZnO NPs, exercise and exercise + ZnO NPs groups. The animal in ZnO NPs and exercise + ZnO NPs groups received 1 mg/kg of ZnO NPs. Rats underwent the treadmill exercise program. Treatments lasted four weeks, 5 days/week. After 4 weeks of treatment, superoxide dismutase (SOD) activity, malondialdehyde (MDA), apelin, Ang II and AT1R concentration were measured in heart tissue.

Cardiac MDA, Ang II and AT1R levels significantly increased while SOD activity and apelin levels significantly decreased following ZnO NPs administration. The aerobic exercise induced a significant increase in the SOD activity and apelin levels and a significant decrease in the enhanced MDA, Ang II and AT1R levels in the heart of ZnO NPs-exposed rats. These results suggest that the exercise-induced attenuation of the Ang II-AT1R signalling pathway is mediated by reduced lipid peroxidation, augmented antioxidant defence and enhanced apelin synthesis that may be a protective mechanism to prevent and/or treatment ZnO NPs-induced cardiac oxidative stress.

Mendoza-Milla, C., Macías Macías, F. I., Velázquez Delgado, K. A., Herrera Rodríguez, M. A., Colín-Val, Z., Ramos-Godinez, M. D. P., Cano-Martínez, A., Vega-Miranda, A., Robledo-Cadena, D. X., Delgado-Buenrostro, N. L., & Chirino, Y. I. (2022). Zinc oxide nanoparticles induce toxicity in H9c2 Rat cardiomyoblasts. International Journal of Molecular Sciences, 23(21), 12940. https://doi.org/10.3390/ijms232112940CrossRefPubMedPubMedCentral

Fadda, L. M., Abdel Baky, N. A., Al-Rasheed, N. M., Al-Rasheed, N. M., Fatanin, A. J., & Atteya, M. (2012). Role of quercetin and arginine ameliorating nano zinc oxide-induced nephrotoxicity in rats. BMC Complementary Medicine and Therapies, 12, 60. https://doi.org/10.1186/1472-6882-12-60CrossRef

Elshama, S., Abdallah, M., & Abdel-Karim, R. (2018). Zinc oxide nanoparticles: Therapeutic benefits and toxicological hazards. The Open Nanomedicine and Nanotechnology Journal, 5, 16–22. https://doi.org/10.2174/1875933501805010016CrossRef

Wang, J., Deng, X., Zhang, F., Chen, D., & Ding, W. (2014). ZnO nanoparticle-induced oxidative stress triggers apoptosis by activating JNK signaling pathway in cultured primary astrocytes. Nanoscale Research Letters, 9(1), 117. https://doi.org/10.1186/1556-276X-9-117CrossRefPubMedPubMedCentral

Scherzad, A., Meyer, T., Kleinsasser, N., & Hackenberg, S. (2017). Molecular Mechanisms of Zinc Oxide Nanoparticle-Induced Genotoxicity Short Running Title: Genotoxicity of ZnO NPs. Materials (Basel), 10(12), 1427. https://doi.org/10.3390/ma10121427CrossRefPubMed

Milivojević, T., Drobne, D., Romih, T., Mali, L. B., Marin, I., Lunder, M., & Drevenšek, G. (2016). Chronic exposure to zinc oxide nanoparticles increases ischemic-reperfusion injuries in isolated rat hearts. Journal of Nanoparticle Research, 18, 309. https://doi.org/10.1007/s11051-016-3573-0CrossRef

Zoheir, M., Medwar, A., Solaiman, A., & Elbanawany, N. (2019). Histological study of the effect of zinc oxide nanoparticles on the cardiomyocytes of adult male albino rats with reference to the role of mitochondria. Egyptian Journal of Histology, 42(3), 567–582. https://doi.org/10.21608/ejh.2019.7112.1065CrossRef

Yan, Z., Wang, W., Wu, Y., Wang, W., Li, B., Liang, N., & Wu, W. (2017). Zinc oxide nanoparticle-induced atherosclerotic alterations in vitro and in vivo. International Journal of Nanomedicine, 12, 4433. https://doi.org/10.2147/IJN.S134897CrossRefPubMedPubMedCentral

Li, X., & Wang, K. (2017). Effects of moderate-intensity endurance exercise on angiotensin II and angiotensin II type I receptors in the rat heart. Molecular medicine reports, 16(3), 2439–2444. https://doi.org/10.3892/mmr.2017.6864CrossRefPubMedPubMedCentral

10.

Chatterjee, P., Gheblawi, M., Wang, K., Vu, J., Kondaiah, P., & Oudit, G. Y. (2020). Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications. Clinical science, 134(17), 2319–2336. https://doi.org/10.1042/CS20200479CrossRefPubMed

11.

Mehta, P. K., & Griendling, K. K. (2007). Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. American journal of physiology. Cell physiology, 292(1), C82-97. https://doi.org/10.1152/ajpcell.00287.2006CrossRefPubMed

12.

Dikalov, S. I., & Nazarewicz, R. R. (2013). Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease. Antioxidants & Redox Signaling, 19(10), 1085–1094. https://doi.org/10.1089/ars.2012.4604CrossRef

13.

Nunes-Silva, A., Rocha, G. C., Magalhaes, D. M., Vaz, L. N., Salviano de Faria, M. H., & Simoes e Silva, A. C. (2017). Physical exercise and ACE2-angiotensin-(1–7)-mas receptor axis of the renin angiotensin system. Protein and peptide letters, 24(9), 809–816. https://doi.org/10.2174/0929866524666170728151401CrossRefPubMed

14.

Chandrasekaran, B., Dar, O., & McDonagh, T. (2008). The role of apelin in cardiovascular function and heart failure. European Journal of Heart Failure, 10(8), 725–732. https://doi.org/10.1016/j.ejheart.2008.06.002CrossRefPubMed

15.

Chun, H. J., Ali, Z. A., Kojima, Y., Kundu, R. K., Sheikh, A. Y., Agrawal, R., Zheng, L., Leeper, N. J., Pearl, N. E., Patterson, A. J., & Anderson, J. P. (2008). Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. The Journal of Clinical Investigation, 118(10), 3343–3354. https://doi.org/10.1172/JCI34871CrossRefPubMedPubMedCentral

16.

Sato, T., Kadowaki, A., Suzuki, T., Ito, H., Watanabe, H., Imai, Y., & Kuba, K. (2019). Loss of apelin augments angiotensin II-induced cardiac dysfunction and pathological remodeling. International Journal of Molecular Sciences, 20(2), 239. https://doi.org/10.3390/ijms20020239CrossRefPubMedPubMedCentral

17.

Sato, T., Suzuki, T., Watanabe, H., Kadowaki, A., Fukamizu, A., Liu, P. P., Kimura, A., Ito, H., Penninger, J. M., Imai, Y., & Kuba, K. (2013). Apelin is a positive regulator of ACE2 in failing hearts. The Journal of Clinical Investigation, 123(12), 5203–5211. https://doi.org/10.1172/JCI69608CrossRefPubMedPubMedCentral

18.

Iwanaga, Y., Kihara, Y., Takenaka, H., & Kita, T. (2006). Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor system. Journal of Molecular and Cellular Cardiology, 41(5), 798–806. https://doi.org/10.1016/j.yjmcc.2006.07.004CrossRefPubMed

19.

Xu, X., Wan, W., Ji, L., Lao, S., Powers, A. S., Zhao, W., Erikson, J. M., & Zhang, J. Q. (2008). Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats. Cardiovascular Research, 78(3), 523–532. https://doi.org/10.1093/cvr/cvn028CrossRefPubMed

20.

Barretti, D. L. M., Magalhães, F. D. C., Fernandes, T., do Carmo, E. C., Rosa, K. T., Irigoyen, M. C., Negrão, C. E., & Oliveira, E. M. (2012). Effects of aerobic exercise training on cardiac renin-angiotensin system in an obese Zucker rat strain. PLoS ONE, 7(10), e46114. https://doi.org/10.1371/journal.pone.0046114CrossRefPubMedPubMedCentral

21.

Raji-amirhasani, A., Joukar, S., Naderi boldaji, V., & Bejeshk, M. (2018). Mild exercise along with limb blood-flow restriction modulates the electrocardiogram, angiotensin, and apelin receptors of the heart in aging rats. The Iranian Journal of Basic Medical Sciences, 21(6), 558–563. https://doi.org/10.22038/IJBMS.2018.24796.6165CrossRefPubMed

22.

Nazari, A., & Chehelcheraghi, F. (2020). Using Apelin and exercise to protect the cardiac cells: synergic effect in ischemia reperfusion injuries treatment in rats. Bratislavske Lekarske Listy, 121(1), 14–21. https://doi.org/10.4149/BLL_2020_00CrossRefPubMed

23.

Peeri, M., Habibian, M., Azarbayjani, M. A., & Hedayati, M. (2013). Protective effect of aerobic exercise against L-NAME-induced kidney damage in rats. Archives of Industrial Hygiene and Toxicology, 64(2), 43–49. https://doi.org/10.2478/10004-1254-64-2013-2260CrossRefPubMed

24.

Farzanegi, P., Abbaszadeh, H., Abbassi Daloii, A., Kazemi, M., Sabbaghian, M., Shoeibi, A., Nabipour, R., Abuhosseini, Z., & Azarbayjani, M. A. (2018). Effects of aerobic exercise on histopathology and toxicology of ZnO and nano ZnO in male rats. Toxicological & Environmental Chemistry, 100(1), 103–114. https://doi.org/10.1080/02772248.2018.1430233CrossRef

25.

Mekrungruangwong, T., Kasetsuwan, P., & Viboolvorakul, S. (2020). Protective effects of exercise training against aged-induced the reduction of cardiac angiogenic capacity in middle-aged rats. Cardiology and Cardiovascular Medicine, 4(1), 58–65. https://doi.org/10.26502/fccm.92920102CrossRef

26.

Xu, X., Zhao, W., Wan, W., Ji, L. L., Powers, A. S., Erikson, J. M., & Zhang, J. Q. (2010). Exercise training combined with angiotensin II receptor blockade reduces oxidative stress after myocardial infarction in rats. Experimental physiology, 95(10), 1008–1015. https://doi.org/10.1113/expphysiol.2010.054221CrossRefPubMedPubMedCentral

27.

Tofas, T., Draganidis, D., Deli, C. K., Georgakouli, K., Fatouros, I. G., & Jamurtas, A. Z. (2019). Exercise-induced regulation of redox status in cardiovascular diseases: The role of exercise training and detraining. Antioxidants, 9(1), 13. https://doi.org/10.3390/antiox9010013CrossRefPubMedPubMedCentral

28.

Cao, P., Ito, O., Ito, D., Rong, R., Zheng, Y., & Kohzuki, M. (2020). Combination of exercise training and SOD mimetic tempol enhances upregulation of nitric oxide synthase in the kidney of spontaneously hypertensive rats. International Journal of Hypertension, 2020, 2142740. https://doi.org/10.1155/2020/2142740CrossRefPubMedPubMedCentral

29.

Chuang, H. C., Juan, H. T., Chang, C. N., Yan, Y. H., Yuan, T. H., Wang, J. S., Chen, H. C., Hwang, Y. H., Lee, C. H., & Cheng, T. J. (2014). Cardiopulmonary toxicity of pulmonary exposure to occupationally relevant zinc oxide nanoparticles. Nanotoxicology, 8(6), 593–604. https://doi.org/10.3109/17435390.2013.809809CrossRefPubMed

30.

Li, Y., Li, F., Zhang, L., Zhang, C., Peng, H., Lan, F., Peng, S., Liu, C., & Guo, J. (2020). Zinc oxide nanoparticles induce mitochondrial biogenesis impairment and cardiac dysfunction in human iPSC-derived cardiomyocytes. International Journal of Nanomedicine, 15, 2669–2683. https://doi.org/10.2147/IJN.S249912CrossRefPubMedPubMedCentral

31.

Sahu, D., Kannan, G. M., Vijayaraghavan, R., Anand, T., & Khanum, F. (2013). Nanosized zinc oxide induces toxicity in human lung cells. ISRN toxicology, 2013, 316075. https://doi.org/10.1155/2013/316075CrossRefPubMedPubMedCentral

32.

Chang, Y. N., Zhang, M., Xia, L., Zhang, J., & Xing, G. (2012). The Toxic Effects and Mechanisms of CuO and ZnO Nanoparticles. Materials (Basel, Switzerland), 5(12), 2850–2871.CrossRef

33.

Zhang, J., Ren, C. X., Qi, Y. F., Lou, L. X., Chen, L., Zhang, L. K., Wang, X., & Tang, C. (2006). Exercise training promotes expression of apelin and APJ of cardiovascular tissues in spontaneously hypertensive rats. Life sciences, 79(12), 1153–1159. https://doi.org/10.1016/j.lfs.2006.03.040CrossRefPubMed

34.

Sabouri, M., Norouzi, J., Zarei, Y., Sangani, M. H., & Hooshmand Moghadam, B. (2020). Comparing High-Intensity Interval Training (HIIT) and Continuous Training on Apelin, APJ, NO, and Cardiotrophin-1 in Cardiac Tissue of Diabetic Rats. Journal of Diabetes Research, 2020(6), 1472514. https://doi.org/10.1155/2020/1472514CrossRefPubMedPubMedCentral

35.

Pisarenko, O. I., Lankin, V. Z., Konovalova, G. G., Serebryakova, L. I., Shulzhenko, V. S., Timoshin, A. A., Tskitishvili, O. V., Pelogeykina, Y. A., & Studneva, I. M. (2014). Apelin-12 and its structural analog enhance antioxidant defense in experimental myocardial ischemia and reperfusion. Molecular and Cellular Biochemistry, 39(1–2), 241–250. https://doi.org/10.1007/s11010-014-2008-4CrossRef

36.

Boal, F., Roumegoux, J., Alfarano, C., Timotin, A., Calise, D., Anesia, R., Drougard, A., Knauf, C., Lagente, C., Roncalli, J., & Desmoulin, F. (2015). Apelin regulates FoxO3 translocation to mediate cardioprotective responses to myocardial injury and obesity. Scientific Reports, 5, 16104. https://doi.org/10.1038/srep16104CrossRefPubMedPubMedCentral

37.

Peng, W. W., Hong, L., Liu, G. Y., Lin, C., Zhao, X. L., Wang, S. Z., Lin, L., & Pan, Y. X. (2019). Prehypertension exercise training attenuates hypertension and cardiac hypertrophy accompanied by temporal changes in the levels of angiotensin II and angiotensin (1–7). Hypertension Research, 42(11), 1745–1756. https://doi.org/10.1038/s41440-019-0297-4CrossRefPubMed

38.

Silva, S. D., Jr., Jara, Z. P., Peres, R., Lima, L. S., Scavone, C., Montezano, A. C., Touyz, R. M., Casarini, D. E., & Michelini, L. C. (2017). Temporal changes in cardiac oxidative stress, inflammation and remodeling induced by exercise in hypertension: Role for local angiotensin II reduction. PLoS ONE, 12(12), e0189535. https://doi.org/10.1371/journal.pone.0189535CrossRefPubMedPubMedCentral

39.

Eguchi, S., Kawai, T., Scalia, R., & Rizzo, V. (2018). Understanding angiotensin II type 1 receptor signaling in vascular pathophysiology. Hypertension, 71(5), 804–810. https://doi.org/10.1161/HYPERTENSIONAHA.118.10266CrossRefPubMed

Title: Protective Role of Short-term Aerobic Exercise Against Zinc Oxide Nanoparticles-Induced Cardiac Oxidative Stress Via Possible Changes of Apelin, Angiotensin II/Angiotensin II Type I Signalling Pathway
Authors: Masoumeh Habibian
Sara Biniaz
Seyyed Jafar Moosavi
Publication date: 15-05-2023
Publisher: Springer US
Published in: Cardiovascular Toxicology / Issue 5-6/2023
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-023-09792-8

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Protective Role of Short-term Aerobic Exercise Against Zinc Oxide Nanoparticles-Induced Cardiac Oxidative Stress Via Possible Changes of Apelin, Angiotensin II/Angiotensin II Type I Signalling Pathway

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5-6/2023

Electropharmacological Characterization of Licorice Using the Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Sheets and the Chronic Atrioventricular Block Dogs

Retraction Note: Ergosterol Attenuates Isoproterenol-Induced Myocardial Cardiotoxicity

The Acute Effect of Trimethylamine-N-Oxide on Vascular Function, Oxidative Stress, and Inflammation in Rat Aortic Rings

Retraction Note: Alpha-Lipoic Acid Protects Against Doxorubicin-Induced Cardiotoxicity by Regulating Pyruvate Dehydrogenase Kinase 4

Cardiovascular Harmful Effects of Recommended Daily Doses (13 µg/kg/day), Tolerable Upper Intake Doses (0.14 mg/kg/day) and Twice the Tolerable Doses (0.28 mg/kg/day) of Copper

Intermittent Hypoxic Preconditioning Plays a Cardioprotective Role in Doxorubicin-Induced Cardiomyopathy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page